PGL prospa group limited.

nexavar trial ends early. incredible success

  1. 498 Posts.
    A phase III trial that ends this early? Who'd have thought it was possible. It's truly mind-blowing. With a blockbuster drug like Nexavar as a competitor, it's time to admit defeat, and get back to the drawing board.

    Look out below.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.